Tirzepatide (Mounjaro, Zepbound) Tirzepatide adds GIP receptor activation to GLP-1 agonism, creating a dual mechanism that achieves approximately 21% weight loss in trials
Focus on protein, balanced nutrition overall and let your body lead you in terms of what allows you to feel and function your best
CVS recent choice marks a reversal from its decision last year to exclude Zepbound from its commercial formularies while maintaining coverage for Novo Nordisks Wegovy following a negotiation for more favorable pricing terms with the Danish drugmaker
And unless you understand exactly how concentration, volume, and units relate to each other, you will either underdose (wasting medication and delaying results) or overdose (triggering severe nausea, vomiting, and potentially dangerous blood sugar drops)
The brand's promotional language refers to those independent providers